(Q54125443)

English

Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study. (English)

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

1 reference

based on heuristic

inferred from title

25

object named as

Fenaux P

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

author name string

Wattel E

1

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Solary E

2

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Hecquet B

3

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Caillot D

4

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Ifrah N

5

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Brion A

6

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Mahé B

7

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Milpied N

8

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Janvier M

9

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Guerci A

10

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Rochant H

11

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Cordonnier C

12

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Dreyfus F

13

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Buzyn A

14

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Hoang-Ngoc L

15

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Stoppa AM

16

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Gratecos N

17

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Sadoun A

18

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Stamatoulas A

19

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Tilly H

20

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Brice P

21

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Maloisel F

22

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Lioure B

23

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Desablens B

24

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

British Journal of Haematology

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

102

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

1015-1024

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

4

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Modulation of mitomycin C-induced multidrug resistance in vitro

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Planning the size and duration of a clinical trial studying the time to some critical event

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

The MDR phenotype in hematologic malignancies: prognostic relevance and future perspectives

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Glutathione-s-transferase pi expression in leukaemia: a comparative analysis with mdr-1 data

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Multicentric evaluation of the MDR phenotype in leukemia. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Multidrug resistance (MDR) gene expression in acute non lymphoblastic leukemia: sequential analysis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Prognostic factors in myelodysplastic syndromes: critical analysis of the impact of age and gender and failure to identify a very-low-risk group using standard mortality ratio techniques.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

MDR1 gene expression and treatment outcome in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Sufficient levels of quinine in the serum circumvent the multidrug resistance of the human leukemic cell line K562/ADM.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Reversal of multidrug resistance in acute myeloid leukaemia and other haematological malignancies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Heavy-chain immunoglobulin gene rearrangement and cytoplasmic immunoglobulin expression in acute monocytic leukemia following primary germ cell tumor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

MULTIDRUG RESISTANCE IN LEUKAEMIA

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

VAD-Cyclosporine Therapy for VAD-Resistant Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00870.X

21 January 2018

Identifiers

10.1046/J.1365-2141.1998.00870.X

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

1 reference

Europe PubMed Central

25 May 2018

http://europepmc.org/abstract/MED/9734653

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54125443&oldid=1313500337"